Taylor Pindi Sala

ORCID: 0000-0002-0243-3980
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Peripheral Neuropathies and Disorders
  • Inflammatory Myopathies and Dermatomyositis
  • Platelet Disorders and Treatments
  • Vitamin C and Antioxidants Research
  • Pharmaceutical studies and practices
  • Systemic Lupus Erythematosus Research
  • Immunodeficiency and Autoimmune Disorders
  • Renal Diseases and Glomerulopathies
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Vasculitis and related conditions
  • Myasthenia Gravis and Thymoma

Patient-Centered Outcomes Research Institute
2020

Université Paris Cité
2020

Weatherford College
2020

Octapharma (France)
2018

Bicêtre Hospital
2014

Assistance Publique – Hôpitaux de Paris
2014

Henoch-Schönlein purpura (HSP) is a systemic vasculitis involving small vessels with deposition of immunoglobulin A (IgA) complexes, usually affecting children. Compared children, HSP in adults more severe and frequently associated cancer. We report the case 49-year-old woman medical history kidney transplantation for segmental glomerular hyalinosis. Eight years after transplantation, while taking combined immunosuppressive therapy tacrolimus azathioprine indicated prevention against...

10.1155/2014/619218 article EN cc-by Case Reports in Medicine 2014-01-01

Patients with primary immunodeficiency (PID) often receive immunoglobulin replacement therapy (IgRT). Physicians and patients have the choice between various methods of administration. For subcutaneous infusions, may use an automated pump (P) or push plunger a syringe (rapid [RP]). P infusions are performed once week last around 1 hour. RP decreases duration administration, but requires more frequent infusions.Eight out 30 (coming from single center) who had participated in cross-over,...

10.2147/ppa.s156983 article EN cc-by-nc Patient Preference and Adherence 2018-03-01

Immunoglobulins are 2nd or 3rd-line treatments in dermatomyositis (DM) polymyositis (PM) refractory to high-dose corticosteroids and immunosuppressants. (2 g/kg/mo) usually administered intravenously (IVIg) once a month the patients stay at hospital for few days. Recently, subcutaneous injections (SCIg) were proposed 2 3 times per week, some dysimmune diseases. SCIg home preferably by patient nurse. We investigated needs attitudes of DM PM with experience IVIg SCIg.Seven (6 1 DM) from single...

10.1097/md.0000000000019012 article EN cc-by-nc Medicine 2020-02-01
Coming Soon ...